Blackbriar-LLC International Consulting Services

03/17/2026

Huge congratulations to Prof. Dr. Thomas Danne on receiving Children with Diabetes’ 2026 President’s Award for Innovation at Advanced Technologies & Treatments for Diabetes (ATTD) Barcelona!

This award honors leaders who are pushing diabetes care forward through innovation—and Dr. Danne’s impact truly speaks for itself. From advancing cutting-edge diabetes technologies to leading global collaboration in research and care, his work has helped shape the future for people living with type 1 diabetes around the world.

As Chief Medical Officer of Breakthrough T1D and a lifelong leader in pediatric diabetology, Dr. Danne has spent decades driving progress in insulin delivery, glucose monitoring, and therapies that help people with T1D not just live—but thrive.

We are honored to celebrate a leader whose dedication continues to change lives across the global T1D community. Thank you, Dr. Danne, for your vision, your leadership, and your unwavering commitment to improving life with diabetes.

03/13/2026

03/13/2026

Science working as it should…

HISTORY

Danish Physician Hans Christian Hagedorn discovers the action of insulin can be prolonged with the addition of protamine in 1936, which ultimately became known as NPH Insulin. This means that people with diabetes can have fewer injections. NPH insulin was not marketed and available until 1946.

02/10/2026

A wonderful recognition for a great guy…

🎉 We would like to congratulate again Professor Joseph Wolfsdorf, recipient of the ISPAD 2025 Prize for Achievement!

A global leader in pediatric diabetes, Prof. Wolfsdorf has dedicated over four decades to advancing care, education, and research.
Read more about his accomplishments: https://loom.ly/kVAd2YI

We are honored to recognize his remarkable impact on generations of healthcare professionals and young people with diabetes worldwide.

👏 Thank you to Eli Lilly for generously supporting this prestigious award.

01/11/2026

On January 11, 1922, Leonard Thompson became the first person to receive insulin treatment, transforming a fatal diagnosis of type 1 diabetes into a manageable condition.

His courage, along with the groundbreaking work of Dr. Frederick Banting, Charles Best, James Collip, and John Macleod, paved the way for millions of people like us to live longer, healthier lives.

Today, we honor the science, the progress, and the lives saved.

01/09/2026

12/16/2025

ACTION ALERT: Protect Healthcare Coverage Access.

Send our pre-written letter with an option to add your own personal message here:
https://diabetespatientadvocacycoalition.quorum.us/campaign/ACAletter/

We are working with the Partnership to Protect Coverage (PPC) to deliver this important message: for people with diabetes who rely on the Enhanced Advance Premium Tax Credit (eAPTC) for coverage, the stakes couldn’t be higher. Without the eAPTC, millions of people will see SIGNIFICANTLY higher insurance premiums.

12/13/2025

This episode of the podcast Diabetes Connections, titled "Inside Capitol Hill's Fight for Diabetes Care," features CEO George Huntley discussing Medicare changes like competitive bidding that could limit seniors’ access to CGMs and pumps, the shifting GLP-1 landscape, and recent patient advocacy wins.

Listen now here or wherever you get podcasts!
https://www.youtube.com/watch?v=JGUfmOPYfP0

10/09/2025

When it comes to prescription drugs, your formulary matters. 📋💊

A formulary is the list of medications your health plan covers. The formulary is decided by pharmacy benefit managers (PBMs).

Knowing what’s included can save you surprise costs and help you plan your care.

10/03/2025

County Executive Marc Elrich among those testifying to the state prescription drug board about the need to rein in costs.

09/24/2025

David A. Ricks, the chair and CEO of Indianapolis-based pharmaceutical giant Eli Lilly and Co., announced plans Tuesday to build a $6.5 billion manufacturing facility in Houston. It'll produce an oral medication for obesity and type 2 diabetes. https://www.wishtv.com/news/business/eli-lilly-and-co-s-6-5b-houston-site-to-produce-oral-drug-for-obesity-diabetes/

09/23/2025

The most recent reported cost of diagnosed diabetes (not including pre-diabetes) in the US is $412.9 billion: $306.6 billion in direct medical costs and $106.3 billion in indirect costs like lost work and productivity.

This number has increased by $80 billion in just a decade.

When diabetes is managed early, we not only reduce the risk of complications — we cut down the costs that come with them.